Previous Close | 1.5200 |
Open | 1.5500 |
Bid | 1.5600 x 700 |
Ask | 1.5900 x 200 |
Day's Range | 1.4700 - 1.6250 |
52 Week Range | 0.4200 - 2.0500 |
Volume | |
Avg. Volume | 1,892,936 |
Market Cap | 389.983M |
Beta (5Y Monthly) | 2.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Adaptimmune Therapeutics ( NASDAQ:ADAP ) Full Year 2023 Results Key Financial Results Revenue: US$60.3m (up 122% from...
Key Financial Highlights and Business Updates
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript March 6, 2024 Adaptimmune Therapeutics plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to Adaptimmune’s Fourth Quarter and Year-End Conference Call and Business Update. I will now […]